INTEGRATED SUPPLY CHAIN SOLUTIONS FOR THE LIFE SCIENCES INDUSTRY

652
Active Clinical Trials
10
Commercial Products
650,000+
Shipments
150+
Countries
Box-for-Q12023 
2022’s Data ManagementTransitionsWebinar

2022’s Data Management Transitions Webinar

Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?

  • How will capacity and connectivity challenges impact carrier services and packaging technology providers?
  • How can you guarantee the certainty of global coverage and data fidelity for your cell and gene therapy shipments?
WATCH NOW
Download our ISO 21973 White Paper

Download our ISO 21973 White Paper

A leap forward in standardizing the regenerative medicine supply chain

  • Ensuring full compliance at every step in the transportation process
  • Standardization at scale
  • Mitigating risk in a zero failure environment
LEARN MORE

The Latest From Our Blog View All

3 Services Your Biopharmaceutical Supply Chain Partner Should Offer

When it comes to choosing a cell and gene therapy shipping partner, not all providers are created equal. To select the best partner for your organization, it’s important to consider how their solutions will meet your needs for today and in the future.  

Exclusive Q&A with Bruce McAfee, Director of Bioservices Commercial Support

Cryoport Systems has extended its expertise in temperature-controlled supply chain solutions with vein-to-vein BioServices offerings. BioServices expands our supply chain solutions in order to better serve our expanding clientele and the greater cell and gene industry. 

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

Cryoport Systems has officially launched Cryoportal® 2. To view the Cryoportal® 2 training materials, please click here.